Updated Date: Wed, 29 Jan 2025 00:00:00 EST
Scientists identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2.
Partnership aims to leverage cutting-edge technology in clinical trials
Designation follows promising preclinical data and FDA clearance
Updated Date: Wed, 29 Jan 2025 00:00:00 EST
Updated Date: Wed, 29 Jan 2025 00:00:00 EST
Updated Date: Tue, 28 Jan 2025 00:00:00 EST
Updated Date: Tue, 28 Jan 2025 00:00:00 EST
Updated Date: Tue, 28 Jan 2025 00:00:00 EST
Breast cancer therapy offers hope for patients at risk of recurrence